$AKTX, $GBS

$DYAI trade broke and I sold for a small loss. Still have it on watch.

$CAPR popped with strong vol on news of competitor $SRPT failing a key trial. I sold my position mostly because I’ve been a bit jaded at this point holding shares. Plus, the pop was mainly attributable to Sarepta’s failure than Capricor’s success. I’ve got plenty of exposure to $CAPR in my IRA and have cash on sidelines if a compelling re-entry point is presented.

Bought $AKTX on chart strength and perennial pending catalysts that seem to have not come to fruition in the past. Hoping, this time it’s different especially given the recent strength in chart.

Also bought small position in $GBS which has a non invasive solution for diabetes monitoring and covid-19 testing. Test kits for covid-19 are currently hot so looking for some volume to hit this recent IPO that has a small float.